GlassScriptPhysician profile
John O Waits
NPI 1396779161
$2,757.62
in general payments reported to CMS, 2019-2025
18 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $545 · 2021: $252 · 2022: $607 · 2023: $344 · 2024: $544 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $729.83 | 2020-2023 | Vibativ |
| Smith+Nephew, INC. | $625.97 | 2020-2025 | Renasys Go V2 Home, Grafix Pl, Oasis |
| La Jolla Pharmaceutical Company | $421.55 | 2022-2025 | Xerava, Xacduro |
| Kci USA, INC. | $186.99 | 2019-2023 | 3m Coban, Activ.A.C. Ion Progress |
| Misonix INC | $173.73 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $124.61 | 2025 | Nuzyra |
| Acell, INC. | $100.68 | 2020 | |
| Urgo Medical North America, LLC | $91.83 | 2025 | Urgoclean Ag |
| Medela LLC | $63.27 | 2024 | Invia Motion Endure |
| Bsn Medical INC | $58.99 | 2025 | |
| Abbvie INC. | $47.85 | 2023-2024 | Dalvance |
| Hartmann USA, INC. | $36.49 | 2022 | |
| Organogenesis INC. | $30.94 | 2024 | |
| Integra Lifesciences Corporation | $23.77 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Melinta Therapeutics, LLC | $20.56 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.64 | 2022 | |
| Advanced Oxygen Therapy INC. | $7.92 | 2023 | Topical Oxygen Chamber For Extremities |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Waits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.